4.6 Article

Maladaptive plasticity in levodopa-induced dyskinesias and tardive dyskinesias: old and new insights on the effects of dopamine receptor pharmacology

Related references

Note: Only part of the references are listed.
Article Psychiatry

Prefrontal cortex volume reductions and tic inhibition are unrelated in uncomplicated GTS adults

Christos Ganos et al.

JOURNAL OF PSYCHOSOMATIC RESEARCH (2014)

Article Clinical Neurology

Age at onset influences neurodegenerative processes underlying PD with levodopa-induced dyskinesias

Antonio Cerasa et al.

PARKINSONISM & RELATED DISORDERS (2013)

Article Clinical Neurology

Prefrontal thickening in PD with levodopa-induced dyskinesias: New evidence from cortical thickness measurement

Antonio Cerasa et al.

PARKINSONISM & RELATED DISORDERS (2013)

Review Neurosciences

Neuronal plasticity and antidepressant actions

Eero Castren et al.

TRENDS IN NEUROSCIENCES (2013)

Editorial Material Clinical Neurology

Do Levodopa Treatments Modify the Morphology of the Parkinsonian Brain?

Anthony C. Vernon et al.

MOVEMENT DISORDERS (2012)

Editorial Material Clinical Neurology

Is executive control used to compensate for involuntary movements in levodopa-induced dyskinesia?

Adam R. Aron et al.

MOVEMENT DISORDERS (2012)

Article Clinical Neurology

Tardive dyskinesia is caused by maladaptive synaptic plasticity: A hypothesis

James T. Teo et al.

MOVEMENT DISORDERS (2012)

Editorial Material Clinical Neurology

PARKINSON DISEASE The controversy of levodopa toxicity in Parkinson disease

Theresa A. Zesiewicz

NATURE REVIEWS NEUROLOGY (2012)

Article Clinical Neurology

Therapies for Dopaminergic-Induced Dyskinesias in Parkinson Disease

Mildred D. Gottwald et al.

ANNALS OF NEUROLOGY (2011)

Article Clinical Neurology

Maladaptive Plasticity of Serotonin Axon Terminals in Levodopa-Induced Dyskinesia

Daniella Rylander et al.

ANNALS OF NEUROLOGY (2010)

Article Behavioral Sciences

Morphological correlates of MAO A VNTR polymorphism: New evidence from cortical thickness measurement

Antonio Cerasa et al.

BEHAVIOURAL BRAIN RESEARCH (2010)

Article Clinical Neurology

Motor Behavior Abnormalities in Drug-Naive Patients with Schizophrenia Spectrum Disorders

Victor Peralta et al.

MOVEMENT DISORDERS (2010)

Article Multidisciplinary Sciences

Amantadine for Dyskinesias in Parkinson's Disease: A Randomized Controlled Trial

Hideyuki Sawada et al.

PLOS ONE (2010)

Review Medicine, Research & Experimental

Maladaptive striatal plasticity in L-DOPA-induced dyskinesia

M. Angela Cenci et al.

RECENT ADVANCES IN PARKINSONS DISEASE: BASIC RESEARCH (2010)

Review Neurosciences

The pathophysiological basis of dystonias

Xandra O. Breakefield et al.

NATURE REVIEWS NEUROSCIENCE (2008)

Review Neurosciences

Molecular mechanisms of L-DOPA-induced dyskinesia

Peter Jenner

NATURE REVIEWS NEUROSCIENCE (2008)

Review Neurosciences

Dopamine dysregulation of movement control in L-DOPA-induced dyskinesia

M. Angela Cenci

TRENDS IN NEUROSCIENCES (2007)

Article Pharmacology & Pharmacy

Brain T1 intensity changes after levodopa administration in healthy subjects: a voxel-based morphometry study

Pilar Salgado-Pineda et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2006)

Review Behavioral Sciences

Inhibition and the right inferior frontal cortex

AR Aron et al.

TRENDS IN COGNITIVE SCIENCES (2004)

Article Clinical Neurology

Presynaptic mechanisms of motor fluctuations in Parkinson's disease:: a probabilistic model

R de la Fuente-Fernández et al.

BRAIN (2004)

Article Multidisciplinary Sciences

Cognitive inflexibility after prefrontal serotonin depletion

HF Clarke et al.

SCIENCE (2004)

Article Neurosciences

Functional significance of the cortico-subthalamo-pallidal 'hyperdirect' pathway

A Nambu et al.

NEUROSCIENCE RESEARCH (2002)

Review Neurosciences

Pathophysiology of the basal ganglia in Parkinson's disease

JA Obeso et al.

TRENDS IN NEUROSCIENCES (2000)